| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8713392 | Journal of Allergy and Clinical Immunology | 2018 | 52 Pages |
Abstract
A-IQOLS provides a reliable, valid, and unique assessment of the patient-perceived negative effect of asthma on QoL that is suitable for use in asthma clinical research and potentially in clinical care. Further studies are needed in diverse patient populations. QOLS, a measure of current QoL, is less sensitive to disease status changes but might be useful in characterizing study populations, in treatment adherence research, and as a clinical and research tool in patients with multiple, severe, and/or life-limiting chronic conditions.
Keywords
PHQ-9ICCNIHOCsQOLACTQuality of lifeAsthmaobstructive sleep apneaOsaAsthma control testStandard error of measurementASUIcoefficient of repeatabilityintraclass correlation coefficientAsthma Symptom Utility IndexNational Institutes of HealthSEMClinical outcomespatient-centered outcomesPatient Health Questionnaireoral corticosteroid
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sandra R. PhD, Michael J. MD, Estela MD, Alan MD, Qiwen MS, Sarah B. PhD, MPH, Santosh MS, Mario MD, MPH, Robert A. MD,